VALGANCICLOVIR Side Effects

6955592-5 | Interstitial Lung Disease
on Aug 17, 2010 Male patient from JAPAN , 34 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Valganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Valganciclovir dosage: . During the same period patient was treated with CELL CEPT (View Cell Cept Review and Cell Cept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), COTRIM (Tdd: Sulfam Ethoxazole: 400 Mg + Trimethoprim: 80 Mg) (View Cotrim Review and Cotrim Label ), GASTER D (View Gaster D Review and Gaster D Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), PROGRAFT (View Prograft Review and Prograft Label ).

6938765-7 | Interstitial Lung Disease
Patient was taking Valganciclovir (View Usage). Patient had the following side effects: interstitial lung disease on Aug 17, 2010 from JAPAN Additional patient health information: Male patient , 34 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Valganciclovir dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), COTRIM (Tdd: Sulfam Ethoxazole: 400 Mg + Trimethoprim: 80 Mg) (View Cotrim Review and Cotrim Label ), GASTER D (View Gaster D Review and Gaster D Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), PROGRAFT (View Prograft Review and Prograft Label ).

6887703-4 | Blood Potassium Increased, Dehydration, Diarrhoea, Electrolyte Imbalance, Malaise, Urosepsis
Adverse event was reported on Jul 26, 2010 by a Female patient taking Valganciclovir (View Usage) (Dosage: Dose:450 Frequency:qd) . Location: UNITED STATES , weighting 145.9 lb, After Valganciclovir was administered, patient had the following side effects: blood potassium increased, dehydration, diarrhoea, electrolyte imbalance, malaise, urosepsis. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PROGRAF (Dose: 0.5) (View Prograf Review and Prograf Label ), ACTOS (Dose: 15 Qd) (View Actos Review and Actos Label ), PHOS NAK (View Phos-nak Review and Phos-nak Label ), PROTONIX (Dose:40 Qd) (View Protonix Review and Protonix Label ), OXYCODONE (Dose: 5 To 10 Mg Q6 Prn) (View Oxycodone Review and Oxycodone Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6848379-5 | Blood Alkaline Phosphatase Increased, Interstitial Lung Disease, Platelet Count Decreased
on Jun 30, 2010 Male patient from JAPAN , 51 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Valganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, interstitial lung disease, platelet count decreased. Valganciclovir dosage: Form And Frequency Not Provided.. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), PRIMPERAN TAB (Started Before Start Of Valganciclovir.) (View Primperan Tab Review and Primperan Tab Label ), MUCOSTA (Started Before Start Of Valganciclovir.) (View Mucosta Review and Mucosta Label ), URSO 250 (Started Before Start Of Valganciclovir.) (View Urso 250 Review and Urso 250 Label ), DIFLUCAN (Started Before Start Of Valganciclovir.) (View Diflucan Review and Diflucan Label ), COTRIM (Started Before Start Of Valganciclovir. Dose: 2 Tablet) (View Cotrim Review and Cotrim Label ), RHYTHMY (Started Before Start Of Valganciclovir.) (View Rhythmy Review and Rhythmy Label ).


6831944-9 | Cytomegalovirus Infection, Myopathy, Transplant Rejection
on Jul 06, 2010 Male patient from UNITED STATES , weighting 163.1 lb, was treated with Valganciclovir (View Usage). Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), myopathy, transplant rejection. Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CP 690550 (View Cp-690550 Review and Cp-690550 Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6817103-4 | Cytomegalovirus Infection, Myopathy, Transplant Rejection
Patient was taking Valganciclovir (View Usage). After Valganciclovir was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), myopathy, transplant rejection on Jun 29, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, . Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CP 690550 (View Cp-690550 Review and Cp-690550 Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6812692-8 | Diabetes Mellitus, Diarrhoea, Pancytopenia, Pulmonary Haemorrhage, Renal Failure Chronic, Thrombocytopenia, Zygomycosis
Adverse event was reported on Jun 28, 2010 by a Male patient taking Valganciclovir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: GERMANY , 60 years of age, Patient experienced the following unwanted or unexpected effects: diabetes mellitus, diarrhoea, pancytopenia, pulmonary haemorrhage, renal failure chronic, thrombocytopenia, zygomycosis. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PENTOSTATIN (View Pentostatin Review and Pentostatin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6767706-0 | Hepatitis, Intestinal Obstruction
on Jun 03, 2010 Male patient from JAPAN , 50 years of age, was diagnosed with transplant rejection and was treated with Valganciclovir (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), intestinal obstruction. Valganciclovir dosage: . During the same period patient was treated with DENOSINE IV (Infusion; 5 Doses A Week) (View Denosine Iv Review and Denosine Iv Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6765816-5 | Aspergillosis, Cerebral Haemorrhage, Cerebral Ischaemia, Cytomegalovirus Infection, Fungal Endocarditis, Hemiplegia, Leukopenia, Pseudallescheria Infection
on Jun 07, 2010 Female patient from FRANCE , 37 years of age, was diagnosed with prophylaxis and was treated with Valganciclovir (View Usage). After Valganciclovir was administered, patient had the following side effects: aspergillosis, cerebral haemorrhage, cerebral ischaemia, cytomegalovirus infection (What is cytomegalovirus infection?), fungal endocarditis, hemiplegia, leukopenia, pseudallescheria infection. Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), TACROLIMUS (Therapeutic Range: 12 To 13.5 Ng/ml) (View Tacrolimus Review and Tacrolimus Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOSCARNET (From Day 97 To 115 And From Day 138 To 151) (View Foscarnet Review and Foscarnet Label ), CASPOFUNGIN ACETATE (On Day 220, Loading Dose) (View Caspofungin Acetate Review and Caspofungin Acetate Label ). Patient was hospitalized.

5956776-5 | Colitis
Patient was taking Valganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: colitis on Nov 06, 2008 from FRANCE Additional patient health information: Female patient , weighting 156.5 lb, was diagnosed with depression (What is depression?), hypertension, immunosuppression and. Valganciclovir dosage: . During the same period patient was treated with DEROXAT (View Deroxat Review and Deroxat Label ), FLODIL (View Flodil Review and Flodil Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), NEORAL (View Neoral Review and Neoral Label ), MYFORTIC (View Myfortic Review and Myfortic Label ). Patient was hospitalized.

5955221-3 | Biliary Anastomosis Complication, Cytomegalovirus Gastrointestinal Infection, Ileus Paralytic, Intestinal Mass, Neutropenia
Adverse event was reported on Nov 03, 2008 by a Male patient taking Valganciclovir (View Usage) (Dosage: ) . Location: SPAIN , 66 years of age, Patient had the following side effects: biliary anastomosis complication, cytomegalovirus gastrointestinal infection, ileus paralytic, intestinal mass, neutropenia. Patient was hospitalized.

4854562-0 | Abdominal Pain Upper, Agranulocytosis, Cytomegalovirus Infection
on Mar 01, 2005 Male patient from FRANCE , 60 years of age, was treated with Valganciclovir (View Usage). After Valganciclovir was administered, patient had the following side effects: abdominal pain upper, agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?). Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (Dose Adjusted To Reach Predefined Target Levels) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

4841790-3 | Agranulocytosis, Cytomegalovirus Infection
on Mar 01, 2005 Male patient from FRANCE , 60 years of age, was treated with Valganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?). Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (Dose Adjusted To Reach Predefined Target Levels) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

4817157-0 | Agranulocytosis, Cytomegalovirus Infection
Patient was taking Valganciclovir (View Usage). Patient had the following side effects: agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?) on Mar 01, 2005 from FRANCE Additional patient health information: Male patient , 60 years of age, . Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (Dose Adjusted To Reach Predefined Target Levels) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

4761876-1 | Pneumonia Cytomegaloviral
Adverse event was reported on Sep 02, 2005 by a Male patient taking Valganciclovir (View Usage) (Dosage: ) . Location: TURKEY , 60 years of age, weighting 176.4 lb, After Valganciclovir was administered, patient had the following side effects: pneumonia cytomegaloviral. During the same period patient was treated with BELOC (View Beloc Review and Beloc Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ), FAMOTIDIN (View Famotidin Review and Famotidin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

4749109-3 | Neutropenia, Pneumonia
on Aug 09, 2005 Male patient from UNITED STATES , 19 years of age, weighting 108.0 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Valganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, pneumonia (What is pneumonia?). Valganciclovir dosage: . During the same period patient was treated with SCH 56592 (View Sch 56592 Review and Sch 56592 Label ). Patient was hospitalized.

4749109-3 | Neutropenia, Pneumonia
on Aug 09, 2005 Male patient from UNITED STATES , 19 years of age, weighting 108.0 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Valganciclovir (View Usage). Patient had the following side effects: neutropenia, pneumonia (What is pneumonia?). Valganciclovir dosage: . During the same period patient was treated with POSACONAZOLE (View Posaconazole Review and Posaconazole Label ). Patient was hospitalized.

4736923-3 | Agranulocytosis, Cytomegalovirus Infection
Patient was taking Valganciclovir (View Usage). After Valganciclovir was administered, patient had the following side effects: agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?) on Mar 01, 2005 from FRANCE Additional patient health information: Male patient , 60 years of age, . Valganciclovir dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (Dose Adjusted To Reach Predefined Target Levels) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ). Patient was hospitalized.

4731579-8 | Agranulocytosis, Cytomegalovirus Infection
Adverse event was reported on Mar 01, 2005 by a Male patient taking Valganciclovir (View Usage) (Dosage: ) . Location: FRANCE , 60 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, cytomegalovirus infection (What is cytomegalovirus infection?). During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (Dose Adjusted To Reach Predefined Target Levels) (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ). Patient was hospitalized.

4678492-2 | Blood Creatinine Increased, Blood Urea Increased, Hyperglycaemia, Hyperkalaemia, Hypertension, Treatment Noncompliance
on Apr 04, 2005 Female patient from , 63 years of age, was treated with Valganciclovir (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, hyperglycaemia, hyperkalaemia, hypertension, treatment noncompliance. Valganciclovir dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

4646745-X | Neutrophil Count Decreased
on Apr 22, 2005 Male patient from , 57 years of age, weighting 207.9 lb, was treated with Valganciclovir (View Usage). After Valganciclovir was administered, patient had the following side effects: neutrophil count decreased. Valganciclovir dosage: .

4600207-4 | Hepatic Failure, Hepatotoxicity, Thrombocytopenia, Viral Infection
Patient was taking Valganciclovir (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, hepatotoxicity, thrombocytopenia, viral infection (What is viral infection?) on Mar 01, 2005 from Additional patient health information: Male patient , 43 years of age, weighting 137.1 lb, . Valganciclovir dosage: Date Of Last Dose Prior To Sae Was 28 Feb 2005. During the same period patient was treated with MMF (View Mmf Review and Mmf Label ), PREDNISONE TAB (22 Apr 2005 To 25 Feb 2005 The Patient Received 7.5 Mg.) (View Prednisone Tab Review and Prednisone Tab Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), LACTULOSE SOLUTION (View Lactulose Solution Review and Lactulose Solution Label ). Patient was hospitalized.

4579164-5 | Abdominal Pain, Blood Phosphorus Decreased, Constipation
Adverse event was reported on Feb 08, 2005 by a Male patient taking Valganciclovir (View Usage) (Dosage: 450 Mg Qod) . Location: , weighting 160.9 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), blood phosphorus decreased, constipation (What is constipation?). During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DAPSONE (View Dapsone Review and Dapsone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PROTONIX (View Protonix Review and Protonix Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), DESFERAL (View Desferal Review and Desferal Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

4579163-3 | Disease Recurrence
on Feb 08, 2005 Female patient from , weighting 184.7 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), prophylaxis and was treated with Valganciclovir (View Usage). After Valganciclovir was administered, patient had the following side effects: disease recurrence. Valganciclovir dosage: 450 Mg Qd.